| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |